Infection in an aging population

Current Opinion in Microbiology

Volumn 29, Issue , 2016, Pages 63-67

  Kline, Kimberly A ^a   Bowdish, Dawn M E ^b  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE INFECTION; HUMAN; IMMUNE SYSTEM; INFECTION SENSITIVITY; INTESTINE FLORA; LOWER RESPIRATORY TRACT INFECTION; MICROBIOME; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMONIA; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; TUBERCULOSIS; URINARY TRACT INFECTION; WOUND INFECTION; ACUTE DISEASE; AGED; BACTERIAL PNEUMONIA; CROSS INFECTION; DISEASE PREDISPOSITION; FEMALE; IMMUNOLOGY; MALE; MICROBIOLOGY; MICROFLORA; RISK FACTOR; VERY ELDERLY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; AGING; BACTERIAL INFECTIONS; CROSS INFECTION; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; MICROBIOTA; PNEUMONIA, BACTERIAL; RISK FACTORS; URINARY TRACT INFECTIONS; WOUND INFECTION;

EID: 84949235352     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2015.11.003     Document Type: Review

References (63)

1. Dorrington M.G., Bowdish D.M. Immunosenescence and novel vaccination strategies for the elderly. Front Immunol 2013, 4:171.
2. Giefing-Kroll C., et al. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell 2015, 14:309-321.
3. Montgomery R.R., Shaw A.C. Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol 2015, pii:jlb.5MR0315-104R. [Epub ahead of print].
4. Geiger H., de Haan G., Florian M.C. The ageing haematopoietic stem cell compartment. Nat Rev Immunol 2013, 13:376-389.
5. Lelic A., et al. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog 2012, 8:e1003076.
6. Aberle J.H., et al. Mechanistic insights into the impairment of memory B cells and antibody production in the elderly. Age (Dordr) 2013, 35:371-381.
7. Kelly C.P., LaMont J.T. Clostridium difficile-more difficult than ever. N Engl J Med 2008, 359:1932-1940.
8. Hazeldine J., et al. Impaired neutrophil extracellular trap formation: a novel defect in the innate immune system of aged individuals. Aging Cell 2014, 13:690-698.
9. Hinojosa E., Boyd A.R., Orihuela C.J. Age-associated inflammation and toll-like receptor dysfunction prime the lungs for pneumococcal pneumonia. J Infect Dis 2009, 200:546-554.
10. Verschoor C.P., et al. Anti-pneumococcal deficits of monocyte-derived macrophages from the advanced-age, frail elderly and related impairments in PI3K-AKT signaling. Hum Immunol 2014, 75:1192-1196.
11. Ebersole J.L., et al. Effects of aging in the expression of NOD-like receptors and inflammasome-related genes in oral mucosa. Mol Oral Microbiol 2015, [Epub ahead of print]. 10.1111/omi.12121.
12. Krone C.L., et al. Respiratory microbiota dynamics following Streptococcus pneumoniae acquisition in young and elderly mice. Infect Immun 2014, 82:1725-1731.
13. Simonetti A.F., et al. Management of community-acquired pneumonia in older adults. Therapeutic advances in infectious disease 2014, 2:3-16.
14. Marik P.E., Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest 2003, 124:328-336.
15. Meyer K.C. The role of immunity and inflammation in lung senescence and susceptibility to infection in the elderly. Semin Respir Crit Care Med 2010, 31:561-574.
16. Mouton C.P., et al. Common infections in older adults. Am Fam Physician 2001, 63:257-268.
17. Meyers B.R., Wilkinson P. Clinical pharmacokinetics of antibacterial drugs in the elderly. Implications for selection and dosage. Clin Pharmacokinet 1989, 17:385-395.
18. Stearns J.C., et al. Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. ISME J 2015, 9:1246-1259.
19. Corrales-Medina V.F., et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA 2015, 313:264-274.
20. Shah F.A., et al. Bidirectional relationship between cognitive function and pneumonia. Am J Respir Crit Care Med 2013, 188:586-592.
21. Yende S., et al. Epidemiology and long-term clinical and biologic risk factors for pneumonia in community-dwelling older Americans: analysis of three cohorts. Chest 2013, 144:1008-1017.
22. Paats M.S., et al. Local systemic cytokine profiles in nonsevere and severe community-acquired pneumonia. Eur Respir J 2013, 41:1378-1385.
23. Iyer A.S., Ohtola J.A., Westerink M.A. Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic. Exp Rev Vaccines 2015, 14:85-97.
24. Foxman B. Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014, 28:1-13.
25. Flores-Mireles A.L., et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 2015, 13:269-284.
26. Laupland K.B., et al. Community-onset urinary tract infections: a population-based assessment. Infection 2007, 35:150-153.
27. Bielecki P., et al. In vivo mRNA profiling of uropathogenic Escherichia coli from diverse phylogroups reveals common and group-specific gene expression profiles. MBio 2014, 5. pe01075-14.
28. Laudisio A., et al. The burden of comorbidity is associated with symptomatic polymicrobial urinary tract infection among institutionalized elderly. Aging Clin Exp Res 2015, 27:805-812.
29. Kline K.A., et al. Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun 2012, 80:4186-4194.
30. Croxall G., et al. Increased human pathogenic potential of Escherichia coli from polymicrobial urinary tract infections in comparison to isolates from monomicrobial culture samples. J Med Microbiol 2011, 60(Pt 1):102-109.
31. Kline K.A., et al. Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model. PLoS ONE 2014, 9:e97798.
32. Luthje P., et al. Estrogen supports urothelial defense mechanisms. Science translational medicine 2013, 5. 190ra80.
33. Wang C., et al. Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model. Infect Immun 2013, 81:733-739.
34. Sen C.K., et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen: Off Publ Wound Healing Soc: Eur Tissue Repair Soc 2009, 17:763-771.
35. Strausbaugh L.J. Emerging health care-associated infections in the geriatric population. Emerg Infect Dis 2001, 7:268-271.
36. Jaul E. Assessment and management of pressure ulcers in the elderly: current strategies. Drugs Aging 2010, 27:311-325.
37. Gist S., et al. Wound care in the geriatric client. Clin Interven Aging 2009, 4:269-287.
38. Pinchinat S., et al. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis 2013, 13:170.
39. Bricout H., et al. Herpes zoster-associated mortality in Europe: a systematic review. BMC Publ Health 2015, 15:466.
40. Nair P., et al. Herpes zoster on the face in the elderly. BMJ Case Rep 2014, pii:bcr2013200101. 10.1136/bcr-2013-200101.
41. Yawn B.P., et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clinic Proc 2007, 82:1341-1349.
42. Langan S.M., et al. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 2013, 10:e1001420.
43. Chan J., Flynn J. The immunological aspects of latency in tuberculosis. Clin Immunol 2004, 110:2-12.
44. Gupta A., et al. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology 2012, 217:363-374.
45. Wiker H.G., et al. Evidence for waning of latency in a cohort study of tuberculosis. BMC Infect Dis 2010, 10:37.
46. Shea K.M., et al. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol 2014, 179:216-225.
47. Claesson M.J., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011, 108(Suppl. 1):4586-4591.
48. Claesson M.J., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
49. O'Sullivan O., et al. Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J Antimicrob Chemother 2013, 68:214-221.
50. Keller J.M., Surawicz C.M. Clostridium difficile infection in the elderly. Clin Geriatr Med 2014, 30:79-93.
51. Lessa F.C., et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015, 372:825-834.
52. Pham V.P., et al. Age-stratified treatment response rates in hospitalized patients with Clostridium difficile infection treated with metronidazole. Antimicrob Agents Chemother 2015, 59:6113-6116.
53. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
54. Regev-Yochay G., et al. Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis 2004, 38:632-639.
55. Whelan F.J., et al. The loss of topography in the microbial communities of the upper respiratory tract in the elderly. Ann Am Thorac Soc 2014, 11:513-521.
56. Walter N.D., et al. Holiday spikes in pneumococcal disease among older adults. N Engl J Med 2009, 361:2584-2585.
57. Lijek R.S., et al. Protection from the acquisition of Staphylococcus aureus nasal carriage by cross-reactive antibody to a pneumococcal dehydrogenase. Proc Natl Acad Sci USA 2012, 109:13823-13828.
58. Lijek R.S., Weiser J.N. Co-infection subverts mucosal immunity in the upper respiratory tract. Curr Opin Immunol 2012, 24:417-423.
59. Chien Y.W., et al. Density interactions among Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in the nasopharynx of young Peruvian children. Pediatr Infect Dis J 2013, 32:72-77.
60. Cremers A.J., et al. The adult nasopharyngeal microbiome as a determinant of pneumococcal acquisition. Microbiome 2014, 2:44.
61. Krone C.L., et al. Carriage of Streptococcus pneumoniae in aged adults with influenza-like-illness. PLoS One 2015, 10:e0119875.
62. de Steenhuijsen Piters W.A., et al. Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J 2015, 1-12. 10.1038/ismej.2015.99.
63. Tate J.A., et al. Infection hospitalization increases risk of dementia in the elderly. Crit Care Med 2014, 42:1037-1046.